Incyte Corporation
INCY
$62.53
$0.500.81%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/3/2025
-
Ticker Report
5/3/2025
-
MarketBeat
5/3/2025
-
Ticker Report
5/2/2025
-
TipRanks Financial Blog
5/2/2025
-
MarketBeat
5/2/2025
-
Ticker Report
5/1/2025
-
MarketBeat
5/1/2025
-
GuruFocus
5/1/2025
-
Simply Wall St
5/1/2025
-
Business Wire
5/1/2025
-
MarketBeat
5/1/2025
-
Ticker Report
5/1/2025
-
MarketBeat
4/30/2025
-
Benzinga
4/30/2025
-
GuruFocus
4/30/2025
-
The Fly
4/30/2025
-
GuruFocus
4/30/2025
-
GuruFocus
4/30/2025
-
GuruFocus
4/30/2025
-
TipRanks Financial Blog
4/30/2025
-
The Fly
4/30/2025
-
TipRanks Financial Blog
4/30/2025
-
The Fly
4/30/2025
-
The Fly
4/30/2025
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 29, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of July (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
302 498 6700
Address
1801 Augustine Cut-Off
Wilmington, DE 19803
Wilmington, DE 19803
Country
Year Founded
Business Description
Sector
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers...
more